Algebris (UK)’s Genenta Science GNTA Stock Holding History

Algebris (UK)’s Portfolio GNTA Stock Details GNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100,000	Closed	-$149K	–	79
2025 Q4	$149K	Hold	100,000	–	–	0.01%	79
2025 Q3	$328K	Hold	100,000	–	–	0.04%	64
2025 Q2	$310K	Hold	100,000	–	–	0.05%	42
2025 Q1	$368K	Buy	100,000 +55,000	+122%	+$221K	0.07%	37
2024 Q4	$181K	Hold	45,000	–	–	0.05%	41
2024 Q3	$170K	Hold	45,000	–	–	0.07%	24
2024 Q2	$131K	Hold	45,000	–	–	0.04%	45
2024 Q1	$146K	Hold	45,000	–	–	0.06%	43
2023 Q4	$186K	Hold	45,000	–	–	0.1%	31
2023 Q3	$225K	Hold	45,000	–	–	0.12%	41
2023 Q2	$267K	Hold	45,000	–	–	0.13%	38
2023 Q1	$271K	Hold	45,000	–	–	0.11%	42
2022 Q4	$242K	Buy	+45,000	New	+$222K	0.11%	42
2022 Q2	–	Sell	-45,000	Closed	-$315K	–	37
2022 Q1	$315K	Hold	45,000	–	–	0.14%	32
2021 Q4	$493K	Buy	+45,000	New	+$510K	0.22%	28

Other funds holding GNTA

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Allianz Munich, Germany $9.02B AUM 28.63% 1-Year Est. Return

AlTi Global New York $4.84B AUM 25.68% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $309M AUM

IAA

Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Algebris (UK)'s GNTA Position: Q1 2026 in Review

Algebris (UK) sold out of Genenta Science (GNTA) in Q1 2026, closing a stake of 100,000 shares — an estimated $149K sold.

Algebris (UK) first reported a position in GNTA in Q4 2021 and held it in 15 quarters. The position peaked at $493K in Q4 2021. 11 funds tracked by Wall St. Rank hold GNTA as of Q1 2026.

Algebris (UK) reported no remaining Genenta Science position as of Q1 2026 after selling out during the quarter.
Algebris (UK) sold 100,000 Genenta Science shares in Q1 2026, an estimated $149K.
Algebris (UK) first reported a position in Genenta Science in Q4 2021 and held it in 15 quarters.
Algebris (UK)'s Genenta Science position peaked at $493K in Q4 2021.
11 funds tracked by Wall St. Rank held Genenta Science as of Q1 2026.

Based on Algebris (UK)'s 13F filing for Q1 2026, filed 13 May 2026.